SCHEMBL1504675

SCHEMBL1504675

CC(NC(=O)OC(C)(C)C)C(C(=O)O)N1CCN(S(C)(=O)=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 1/20 0.34
CTSK P43235 4/20 0.34
CTSL P07711 3/20 0.34
CTSB P07858 2/20 0.34
CTSS P25774 3/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2681100 0.84 CTSK (0.43) PREPKMT2AMEN1CA1CA2
SCHEMBL1503591 0.82 CTSK (0.42) PREPKMT2AMEN1CA1CA2
SCHEMBL1504639 0.81 MEN1 (0.32) KMT2AMEN1POLBMAPK1CASP1
SCHEMBL1504589 0.81 CA1 (0.41) PREPKMT2ACA1CA2CA7
SCHEMBL1503616 0.80 CTSK (0.45) PREPKMT2AMEN1CA1CA2
SCHEMBL995014 0.74 ADAM17 (0.43) KMT2AMEN1
SCHEMBL995255 0.74 ADAM17 (0.43) KMT2AMEN1
SCHEMBL995012 0.74 ADAM17 (0.43) KMT2AMEN1
SCHEMBL1504753 0.74 POLB (0.47) KMT2AMEN1CYP2D6CYP2C19CTSL
SCHEMBL12077753 0.72 TP53 (0.33) KMT2AMEN1CYP2D6CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033009-A1 N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed